Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsModality Solutions was included in the 2020 Company Focus & Industry Reference Guide published by Pharmaceutical Outsourcing™ The Journal of Pharmaceutical & Biopharmaceutical Contract Services. Modality Solutions was included in the guide in the Pharmaceutical Cold Chain Management Solutions section.
According to Editor-in-Chief, Mike Auerbach, in the Pharmaceutical Outsourcing Vol. 20 Issue 5, November 2019, “The pharmaceutical contract manufacturing, development and services sector of the industry continues to grow in size and importance. A quick look at the most recent research and market outlook reports all point to strong growth in every sector of the contract services market in the coming years.”
Pharmaceutical Outsourcing is the leading review of business and technology for the pharmaceutical industry throughout North America. It is dedicated to pharmaceutical and biopharmaceutical contract services, and the publication has regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research, and other areas.
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details